# Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO

> **NCT00566761** · PHASE4 · TERMINATED · sponsor: **Asociación para Evitar la Ceguera en México** · enrollment: 10 (actual)

## Conditions studied

- Macular Edema
- Central Retinal Vein Occlusion

## Interventions

- **DRUG:** bevacizumab and triamcinolone

## Key facts

- **NCT ID:** NCT00566761
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2007-06
- **Final completion:** 2008-03
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** undefined
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00566761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00566761, "Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00566761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*